Knowthestock.com
BEAT - BioTelemetry, Inc.

Sell

Moderate Growth but DecliningStock Price Very High

52%

based on last 5 year data.
Income Statement is MODERATE
Revenue Growth is 1.89%
Operating Income Growth is -39.19%
Net Income Growth is -54.27%
Earnings Per Share (EPS) Growth is -56.07%
Net Margin is 4.03%
Balance Sheet is STRONG
Current Asset to Current Liability Ratio is 2.8
Debt Ratio is 0.46
Current Debt to Net Income Ratio is 0.0
Total Debt to Total Assets Ratio is 0.21
Cash Flow is STRONG
Cash from Operations Growth is 31.24%
Capital Expenditure is High
Net Increase in Cash is Positive
Long Term Score Trend is NEGATIVE
Investment Risk is High
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
BioTelemetry, Inc. (BEAT) - http://www.biotelinc.com
BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The firm also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through the following segments: Healthcare, and Research. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA.
Exchange - NASDAQ
Industry - Medical Specialties
Sector - Health Technology
CEO - Joseph H. Capper
Employees - 1,700
    Close


Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.